200 related articles for article (PubMed ID: 9147642)
21. A Review on
Heidarzadehpilehrood R; Pirhoushiaran M; Abdollahzadeh R; Binti Osman M; Sakinah M; Nordin N; Abdul Hamid H
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205347
[TBL] [Abstract][Full Text] [Related]
22. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome.
Wang Y; Wu X; Cao Y; Yi L; Chen J
Fertil Steril; 2006 Jul; 86(1):223-6. PubMed ID: 16764871
[TBL] [Abstract][Full Text] [Related]
23. Genetic abnormalities in polycystic ovary syndrome.
Franks S; Gharani N; McCarthy M
Ann Endocrinol (Paris); 1999 Jul; 60(2):131-3. PubMed ID: 10456185
[TBL] [Abstract][Full Text] [Related]
24. Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.
Kaur R; Kaur T; Kaur A
J Assist Reprod Genet; 2018 Jun; 35(6):1123-1129. PubMed ID: 29564739
[TBL] [Abstract][Full Text] [Related]
25. Association of the
Munawar Lone N; Babar S; Sultan S; Malik S; Nazeer K; Riaz S
Gynecol Endocrinol; 2021 May; 37(5):456-461. PubMed ID: 32960117
[TBL] [Abstract][Full Text] [Related]
26. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.
Xita N; Lazaros L; Georgiou I; Tsatsoulis A
Fertil Steril; 2010 Jun; 94(1):250-4. PubMed ID: 19324338
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms of pentanucleotide repeats (tttta)n in the promoter of CYP11A1 and their relationships to polycystic ovary syndrome (PCOS) risk: a meta-analysis.
Yu M; Feng R; Sun X; Wang H; Wang H; Sang Q; Jin L; He L; Wang L
Mol Biol Rep; 2014 Jul; 41(7):4435-45. PubMed ID: 24610422
[TBL] [Abstract][Full Text] [Related]
28. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
[TBL] [Abstract][Full Text] [Related]
29. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.
Urbanek M; Legro RS; Driscoll DA; Azziz R; Ehrmann DA; Norman RJ; Strauss JF; Spielman RS; Dunaif A
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8573-8. PubMed ID: 10411917
[TBL] [Abstract][Full Text] [Related]
30. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
Chaudhary H; Patel J; Jain NK; Joshi R
J Ovarian Res; 2021 Sep; 14(1):125. PubMed ID: 34563259
[TBL] [Abstract][Full Text] [Related]
31. Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome.
Baldani DP; Skrgatic L; Cerne JZ; Oguic SK; Gersak BM; Gersak K
Mol Med Rep; 2015 May; 11(5):3941-7. PubMed ID: 25530260
[TBL] [Abstract][Full Text] [Related]
32. Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women.
Calvo RM; Asunción M; Tellería D; Sancho J; San Millán JL; Escobar-Morreale HF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1746-9. PubMed ID: 11297612
[TBL] [Abstract][Full Text] [Related]
33. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
34. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.
Peral B; San Millán JL; Castello R; Moghetti P; Escobar-Morreale HF
J Clin Endocrinol Metab; 2002 Aug; 87(8):3977-83. PubMed ID: 12161545
[TBL] [Abstract][Full Text] [Related]
35. Molecular progress in infertility: polycystic ovary syndrome.
Legro RS; Strauss JF
Fertil Steril; 2002 Sep; 78(3):569-76. PubMed ID: 12215335
[TBL] [Abstract][Full Text] [Related]
36. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.
Petry CJ; Ong KK; Michelmore KF; Artigas S; Wingate DL; Balen AH; de Zegher F; Ibáñez L; Dunger DB
Hum Reprod; 2005 Jul; 20(7):1837-43. PubMed ID: 15802318
[TBL] [Abstract][Full Text] [Related]
37. [Polymorphism of CYP11A1 gene in Chinese patients with polycystic ovarian syndrome].
Gao GH; Cao YX; Yi L; Wei ZL; Xu YP; Yang C
Zhonghua Fu Chan Ke Za Zhi; 2010 Mar; 45(3):191-6. PubMed ID: 20450755
[TBL] [Abstract][Full Text] [Related]
38. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.
Lecke SB; Morsch DM; Spritzer PM
Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013
[TBL] [Abstract][Full Text] [Related]
39. CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome.
Pusalkar M; Meherji P; Gokral J; Chinnaraj S; Maitra A
Fertil Steril; 2009 Aug; 92(2):653-9. PubMed ID: 18725155
[TBL] [Abstract][Full Text] [Related]
40. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
Ferk P; Teran N; Gersak K
Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
